SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-19-018434
Filing Date
2019-04-05
Accepted
2019-04-05 16:35:32
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv518239_s3.htm S-3 238106
2 EXHIBIT 5.1 tv518239_ex5-1.htm EX-5.1 23814
3 EXHIBIT 23.1 tv518239_ex23-1.htm EX-23.1 2481
4 GRAPHIC tv518239_img01.jpg GRAPHIC 9970
5 GRAPHIC tv518239_img02.jpg GRAPHIC 4248
  Complete submission text file 0001144204-19-018434.txt   285281
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-230742 | Film No.: 19735552
SIC: 2836 Biological Products, (No Diagnostic Substances)